Tenon Medical, Inc. (NASDAQ:TNON – Get Free Report) was the recipient of a large growth in short interest in the month of June. As of June 30th, there was short interest totaling 2,375,230 shares, a growth of 826.2% from the June 15th total of 256,462 shares. Approximately 24.4% of the shares of the stock are sold short. Based on an average daily volume of 34,584,964 shares, the short-interest ratio is currently 0.1 days.
Analyst Ratings Changes
Several analysts recently issued reports on the company. Alliance Global Partners reissued a “buy” rating on shares of Tenon Medical in a research note on Wednesday, May 13th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Tenon Medical in a report on Monday, April 20th. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold”.
Check Out Our Latest Research Report on Tenon Medical
Institutional Trading of Tenon Medical
Tenon Medical Stock Down 2.1%
Tenon Medical stock traded down $0.00 during midday trading on Friday, reaching $0.23. 660,152 shares of the stock traded hands, compared to its average volume of 21,680,988. The stock has a market cap of $2.67 million, a P/E ratio of -0.17 and a beta of 1.36. The stock’s fifty day moving average is $0.57 and its 200-day moving average is $0.75. Tenon Medical has a 12 month low of $0.22 and a 12 month high of $2.48.
Tenon Medical (NASDAQ:TNON – Get Free Report) last released its quarterly earnings data on Tuesday, May 12th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.30) by ($0.01). Tenon Medical had a negative return on equity of 907.60% and a negative net margin of 270.09%.The firm had revenue of $1.38 million during the quarter, compared to the consensus estimate of $1.30 million.
Tenon Medical Company Profile
Tenon Medical, Inc is a development-stage medical device company focused on the research, development and commercialization of next-generation surgical biologic adhesives and sealants. The company’s proprietary platform is designed to create tissue-compatible adhesives that can serve as alternatives or complements to traditional sutures and staples, with the goal of improving surgical efficiency, reducing postoperative complications and enhancing patient outcomes.
Tenon Medical’s product pipeline centers on protein-based polymer formulations that cross-link in situ to form a flexible, yet durable, bond with native tissue.
Featured Stories
- Five stocks we like better than Tenon Medical
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
